4//SEC Filing
Blaustein Marc 4
Accession 0001209191-22-013774
CIK 0001733257other
Filed
Feb 27, 7:00 PM ET
Accepted
Feb 28, 6:51 PM ET
Size
5.5 KB
Accession
0001209191-22-013774
Insider Transaction Report
Form 4
Blaustein Marc
Chief Operating Officer
Transactions
- Award
Employee Stock Option (right to buy)
2022-02-25+38,000→ 38,000 totalExercise: $8.61Exp: 2032-02-24→ Common Stock (38,000 underlying)
Footnotes (1)
- [F1]This option vests in equal monthly installments over a four-year period commencing on February 1, 2022, subject to the Reporting Person's continuous service as of the applicable vesting date.
Documents
Issuer
Finch Therapeutics Group, Inc.
CIK 0001733257
Entity typeother
Related Parties
1- filerCIK 0001880032
Filing Metadata
- Form type
- 4
- Filed
- Feb 27, 7:00 PM ET
- Accepted
- Feb 28, 6:51 PM ET
- Size
- 5.5 KB